Jupiter Research Capital (Asia) Ltd’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Jupiter Research Capital (Asia) Ltd's MRNA Position: Q3 2026 in Review
Jupiter Research Capital (Asia) Ltd opened a new position in Moderna (MRNA) in Q3 2026: 74,918 shares worth $14.4M. The stake represents 1.59% of the portfolio and ranks #7 among its holdings. This is a return to the name: Jupiter Research Capital (Asia) Ltd previously reported a position in MRNA as recently as Q1 2026.
Jupiter Research Capital (Asia) Ltd first reported a position in MRNA in Q1 2026 and has held it in 2 quarters since. 972 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- Jupiter Research Capital (Asia) Ltd held 74,918 shares of Moderna worth $14.4M as of Q3 2026.
- Moderna was a new Jupiter Research Capital (Asia) Ltd position in Q3 2026.
- Moderna made up 1.59% of Jupiter Research Capital (Asia) Ltd's portfolio in Q3 2026, its #7 holding.
- Jupiter Research Capital (Asia) Ltd first reported a position in Moderna in Q1 2026 and has held it in 2 quarters since.
- 972 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.